Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
Self-testing Self-testing and self-sampling can support equitable access to testing to everyone, regardless of their location or social status.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Press release FIND and the Helmsley Charitable Trust partner to improve access to continuous glucose self-monitoring devices in Kenya and South Africa
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
To G20 leaders To uphold diagnostics and equitable access to testing within their commitments to support sustainable recovery from COVID-19.
Following a Women Political Leaders' Summit, to global leaders On the urgent need to scale up testing and ensure immediate equitable access to diagnostics.
To WHO Member States To commit to gender equality and human rights in the new international instrument to maintain a firm focus on equitable prevention, preparedness and response that leaves no one behind.
